BridgeMD
Compares treatment options for Local
Official title Local vs Systemic Methotrexate in Management of Uterine Ectopic Pregnancy
ClinicalTrials.gov ID: NCT06554470
What this study is testing
What is Systemic Methotrexate?
Systemic Methotrexate is an investigational medicine, given as an injection into a muscle, being studied as a potential treatment for local.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to compare local and systemic methotrexate in the management of uterine ectopic pregnancy regarding the duration of beta human chorionic gonadotropin (hCG) clearance and need for further management options.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 40, women only
You may be able to join if
- Age from 20 to 40 years.
- Women with uterine ectopic pregnancy (interstitial pregnancy, cervical pregnancy, or cesarean scar pregnancy).
- Gestational age is less than 9 weeks, the embryo size is smaller than 10 mm, and the serum beta-human chorionic gonadotropin (β-hCG) levels are less...
You likely can't join if
- Patients with basal beta hCG levels less than 1500 mIU/Ml.
- Any contraindications to MTX as a hepatic disorder, renal disorder and thrombocytopenia
- Diabetes mellitus.
- Severe vaginal bleeding or hemodynamic changes or hemoperitoneum.
- History of cancer.
- Ascites.
See the full eligibility criteria
- Age from 20 to 40 years.
- Women with uterine ectopic pregnancy (interstitial pregnancy, cervical pregnancy, or cesarean scar pregnancy).
- Gestational age is less than 9 weeks, the embryo size is smaller than 10 mm, and the serum beta-human chorionic gonadotropin (β-hCG) levels are less than 10,000 mIU/mL.
- Patients with basal beta hCG levels less than 1500 mIU/Ml.
- Any contraindications to MTX as a hepatic disorder, renal disorder and thrombocytopenia
- Diabetes mellitus.
- Severe vaginal bleeding or hemodynamic changes or hemoperitoneum.
- History of cancer.
- Ascites.
- Pleural effusion.
The study team makes the final eligibility decision.
Where it's taking place
- Tanta, El-Gharbia, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 20 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tanta, El-Gharbia, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.